[HSF] HIT and CPB
EPS-CCV
epsccv at arrakis.es
Fri Jun 1 08:59:39 EDT 2007
Hal
Prostacyclin does not prevent antibodies forming / resistance developing, obviously. The reasons why we use it are its short half-life (epoprostenol 6 minutes) and the complete inhibition of the heparin-dependent platelet aggregation induced by HIT-II. That way you can use heparin "safely".
Of course we'd prefer not to use heparin. The thing is that neither bivalirudin nor ECT & TAS Analyzer are available here. In addition, "our" protocol seems to be safe and effective.
Enrique P. de la Sota, FECTS
Madrid - Spain
More information about the OpenHeart-L
mailing list